AMA submission to the government review of complementary medicines regulation

17 Jan 2017

The AMA lodged a submission in response to a consultation paper on complementary medicines regulation, released as part of a broader government review of medicines and medical devices regulation. The AMA’s views are that:

  • quality and safety should be the primary objectives of a regulatory framework for complementary medicines
  • the current regulatory approach provides a reasonable balance between the needs of sponsors and consumers
  • ongoing regulation by an independent body such as the TGA is necessary to protect the public from misleading and fraudulent claims.

The AMA’s other submissions to the review are provided in the following links: